Navigation Links
Simbionix and AABIP Sign Collaboration Agreement
Date:11/2/2010

Simbionix and AABIP Sign Collaboration Agreement -- CLEVELAND, November 2, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Education, Contracts, Joint Ventures, New Products & Services Click to view news release full screen  

Simbionix and AABIP Sign Collaboration Agreement

 

CLEVELAND, November 2, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation technology, is pleased to announce they have signed a collaboration agreement with the American Association for Bronchology and Interventional Pulmonology (AABIP) on the development of a Bronchoscopic Essential Skills module.

Simbionix new Bronchoscopy essential skills module is being developed in conjunction with, and endorsed by the AABIP. The new module offers designated skill tasks covering the spectrum of Bronchoscopic skills required. This module is intended to provide the trainee with solid habits for safe and efficient performance, and to enhance hand-eye coordination, 3D perception and anatomical knowledge.

Gerard Silvestri, AABIP President, said that "The daily practice of clinicians is highly affected by the progression of medical technologies, as they are required to adapt to fast changes and developments. It is therefore essential to develop new training programs that utilize the advanced technologies, such as virtual reality simulators, to assure that the educational curriculum is entirely covered. We chose to work with simbionix since we believe that only close collaboration between the medical community and companies that provide cutting edge technologies are essential to successfuly design these programs for the benefit of the physicians, the patients and the entire medical field."

"We are very excited to have reached yet another collaboration agreement with a leading medical society" commented Mr. Ran Bronstein, Simbionix President. "All of our products are designed with the cooperation of the medical community, who play an active role in simulation design, content definition, and product testing and validation. Simbionix continuously provides the procedural and technological know-how and actively joins forces with the leading medical associations and the medical industry to optimize training solutions and to advance clinical performance."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com

About the American Association for Bronchology and Interventional Pulmonology

AABIP is dedicated to promoting excellence in clinical care, education, and research in the rapidly expanding fields of Bronchoscopy, Interventional Pulmonology, and Interventional Bronchoscopy.

For more information on the AABIP, visit http://www.aabronchology.org Contact: Rebecca Zitter Manager of Marketing Communications and Distributor Relations rebecca@simbionix.com +1-216-2292040
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
4. Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
5. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
6. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
7. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
8. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
9. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
10. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
11. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):